These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9532003

  • 1. Localization of insulin-like growth factor-II mRNA in human pituitary adenomas.
    Yokoyama S, Thapar K, Kovacs K, Stefaneanu L.
    Virchows Arch; 1998 Mar; 432(3):241-6. PubMed ID: 9532003
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.
    Li J, Stefaneanu L, Kovacs K, Horvath E, Smyth HS.
    Virchows Arch A Pathol Anat Histopathol; 1993 Mar; 422(3):193-201. PubMed ID: 8493775
    [Abstract] [Full Text] [Related]

  • 3. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H, Saeger W.
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.
    Otsuka F, Tamiya T, Yamauchi T, Ogura T, Ohmoto T, Makino H.
    Regul Pept; 1999 Aug 31; 83(1):31-8. PubMed ID: 10498342
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
    Asano K, Kubo O, Tajika Y, Huang MC, Takakura K.
    No To Shinkei; 1996 Jun 31; 48(6):543-9. PubMed ID: 8703557
    [Abstract] [Full Text] [Related]

  • 9. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S, Takahashi M, Hara M, Hattori A, Sano T, Ozawa Y, Shishiba Y, Hirata K, Usui M.
    Clin Endocrinol (Oxf); 1996 Sep 31; 45(3):263-72. PubMed ID: 8949563
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N, Teramoto A, Matsuno A, Takekoshi S, Osamura RY.
    J Clin Endocrinol Metab; 1995 Aug 31; 80(8):2518-22. PubMed ID: 7543115
    [Abstract] [Full Text] [Related]

  • 12. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin messenger RNA in growth-hormone-secreting pituitary adenomas by in situ hybridization.
    Uhlig H, Saeger W, Fehr S, Lüdecke DK.
    Virchows Arch A Pathol Anat Histopathol; 1991 Aug 31; 418(6):539-46. PubMed ID: 2058088
    [Abstract] [Full Text] [Related]

  • 13. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A, Morandi L, Leonardi E, Farnedi A, Marucci G, Sisto A, Frank G, Faustini-Fustini M, Zoli M, Mazzatenta D, Agati R, Foschini MP.
    Hum Pathol; 2013 Nov 31; 44(11):2400-9. PubMed ID: 24007691
    [Abstract] [Full Text] [Related]

  • 14. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W, Lüdecke B, Lüdecke DK.
    Exp Clin Endocrinol Diabetes; 2008 Feb 31; 116(2):80-5. PubMed ID: 18072009
    [Abstract] [Full Text] [Related]

  • 15. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B, Korbonits M, Diaz-Cano S, Kaltsas G, Morris DG, Jordan S, Metherell L, Powell M, Czirják S, Arnaldi G, Bustin S, Boscaro M, Mantero F, Grossman AB.
    Clin Endocrinol (Oxf); 2003 Sep 31; 59(3):328-38. PubMed ID: 12919156
    [Abstract] [Full Text] [Related]

  • 16. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
    Kim K, Arai K, Sanno N, Osamura RY, Teramoto A, Shibasaki T.
    Clin Endocrinol (Oxf); 2001 Jun 31; 54(6):759-68. PubMed ID: 11422110
    [Abstract] [Full Text] [Related]

  • 17. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC, Pekmezci M, Lavezo JL, Vogel H, Katznelson L, Fraenkel M, Harsh G, Dulai M, Perry A, Tihan T.
    Endocr Pathol; 2017 Dec 31; 28(4):287-292. PubMed ID: 28994039
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Morphological characterization and subtyping of silent somatotroph adenomas.
    Naritaka H, Kameya T, Sato Y, Furuhata S, Otani M, Kawase T.
    Pituitary; 1999 May 31; 1(3-4):233-41. PubMed ID: 11081203
    [Abstract] [Full Text] [Related]

  • 20. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas.
    Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R, Smyth H.
    J Clin Endocrinol Metab; 1994 Jan 31; 78(1):83-8. PubMed ID: 8288720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.